Product Information
IBUPROFEN 200 MG CAPLET is a generic product labeled by Cardinal Health, priced at $0.0331 per EA under NDC 70000000301. Its NADAC has been published 335 times since May 6, 2020.
FDA first approved this application on Jun 21, 2005.
Strength
200 mg/1
Manufacturer
Cardinal HealthNDC
70000000301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA077349FDA Approved
6/21/2005
On Market Since
12/18/2019
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 200 MG CAPLET has been published 335 times since May 6, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0331 per EA |
|---|---|
| All-time high | $0.0370 (Nov 12, 2025) |
| All-time low | $0.0300 (Apr 17, 2024) |
| 52-week high | $0.0370 |
| 52-week low | $0.0320 |
| Median price | $0.0333 |
| Average price | $0.0335 |
| Largest weekly change | -13.7% (Apr 17, 2024) |
| Weeks tracked | 335 |
| Tracking since | May 6, 2020 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IBUPROFEN 200 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 200 MG CAPLET, manufactured by Cardinal Health, is $0.0331 per EA (NDC 70000000301), effective Sep 30, 2026.
How has the price of IBUPROFEN 200 MG CAPLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 200 MG CAPLET has held within roughly two percent of its current level. It has been tracked across 335 weekly CMS publications since May 6, 2020.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 200 MG CAPLET?
Since May 6, 2020, the NADAC for IBUPROFEN 200 MG CAPLET has ranged from a low of $0.0300 (Apr 17, 2024) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0333 per EA.
Are there cheaper alternatives to IBUPROFEN 200 MG CAPLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 19% below IBUPROFEN 200 MG CAPLET.
Who manufactures IBUPROFEN 200 MG CAPLET?
IBUPROFEN 200 MG CAPLET (NDC 70000000301) is labeled by Cardinal Health, and CMS classifies it as a generic product.